Lycus Pharma Private Limited
Pharmaceutical trading and supply company with a wide range of products.
2009 | Pathanamthitta, Kerala (India) | Active
Lycus Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 M
- Revenue Growth 26.77%
- Profit Growth -14.02%
- Ebitda -2611.72%
- Net Worth 12.89%
- Total Assets 25.88%
About Lycus Pharma
Lycus Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 July 2009 and has a history of 15 years and seven months. Its registered office is in Pathanamthitta, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Jose Joseph, Lathish Nair, Jayan Padmanabhan, and One other member serve as directors at the Company.
Company Details
- Location
Pathanamthitta, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52311KL2009PTC024412
- Company No.
024412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Pharma
Who are the key members and board of directors at Lycus Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lathish Nair  | Managing Director | 30-Mar-2012 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jose Joseph | Director | 06-Jul-2009 | Current |
| Jayan Padmanabhan | Director | 30-Mar-2012 | Current |
| Jacob Job | Director | 30-Mar-2012 | Current |
Financial Performance of Lycus Pharma.
Lycus Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.77% increase. The company also saw a substantial fall in profitability, with a 14.02% decrease in profit. The company's net worth Soared by an impressive increase of 12.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lycus Pharma?
In 2019, Lycus Pharma had a promoter holding of 18.90% and a public holding of 81.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Feb 2015 | Others | ₹1.50 M | Open |
How Many Employees Work at Lycus Pharma?
Unlock and access historical data on people associated with Lycus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lycus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lycus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Lycus Pharma
Recent activity within the organization
- Annual General Meeting
Lycus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Lycus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.
- Charges
A charge with Others of Rs. 1.50 M registered on 09 Feb 2015 with Charge ID 10549521 was modified on 20 Jun 2016.
- Charges
A charge with Others amounted to Rs. 1.50 M with Charge ID 10549521 was registered on 09 Feb 2015.
- Director Appointment
Lathish Pulickaparambil Narayanan Nair was appointed as a Managing Director was appointed as a Managing Director on 30 Mar 2012 & has been associated with this company since 12 years 11 months .
- Director Appointment
Jayan Padmanabhan was appointed as a Director was appointed as a Director on 30 Mar 2012 & has been associated with this company since 12 years 11 months .
Frequently asked questions
What is the Incorporation or founding date of Lycus Pharma Private Limited?
Lycus Pharma Private Limited was incorporated on 06 Jul 2009.
What is authorized share capital and paid-up capital of Lycus Pharma Private Limited?
The authorized share capital of Lycus Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Lycus Pharma Private Limited?
Currently 4 directors are associated with Lycus Pharma Private Limited.
- Jose Joseph
- Lathish Pulickaparambil Narayanan Nair
- Jayan Padmanabhan
- Jacob Job
What is the registered address of Lycus Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Lycus Pharma Private Limited is Xiii/331/1 Anjiliveeliyil Building, Near Ymca India, Tiruvalla, Kerala, 689101.
What is the corporate identification number (CIN) and company number of Lycus Pharma Private Limited?
The corporate identification number (CIN) of Lycus Pharma Private Limited is U52311KL2009PTC024412 and the company number is 024412 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Lycus Pharma Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Lycus Pharma Private Limited has risen by 26.77%.
What change has been observed in the net worth of Lycus Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Lycus Pharma Private Limited has experienced an upsurge of 12.89%.
What are the total open charges for Lycus Pharma Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Lycus Pharma Private Limited amount to ₹ 1.50 M.
When was the last Balance Sheet of Lycus Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Lycus Pharma Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
RP
Ramesh PanickerManaging Director
Similar Companies Based on Pharmaceutical Retailers & Distributors
Wellness Forever Medicare Limited Mumbai, Maharashtra, India
Sun Pharma Distributors Limited Mumbai, Maharashtra, India
Novartis Healthcare Private Limited Mumbai, Maharashtra, India
Mylan Pharmaceuticals Private Limited Hyderabad, Telangana, India
Msd Pharmaceuticals Private Limited New Delhi, Delhi, India
Aster Dm Healthcare Limited Bangaluru, Karnataka, India
Reckitt Benckiser Healthcare India Private Limited Gurugram, Haryana, India
Trident Chemphar Limited Hyderabad, Telangana, India